HIV patients with CD4 counts less than 50 who received Mycobacterium avium complex (MAC) prophylaxis

Measure Source

The HIV Research Network.

Tables

1.60 HIV patients age 18 and over with CD4 cell count less than 50 who received MAC prophylaxis, by race, United States, 2002, United States,.

Data Source

HIV Research Network, sponsored by multiple Federal agencies: the Agency for Healthcare Research and Quality (AHRQ), the Center for Substance Abuse Treatment in the Substance Abuse and Mental Health Services Administration (SAMHSA), the HIV/AIDS Bureau in the Health Resources and Services Administration (HRSA), and the Office of AIDS Research in the Office of the Director of the National Institutes of Health (OAR/NIH).

Denominator

Patients diagnosed with HIV with CD4 counts < 50 cells/mm.

Numerator

Subset of denominator who received MAC prophylactic therapy.

Comments

For further information see Centers for Disease Control and Prevention. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR 2004; 53 (No. RR-15): available from the CDC website at http://www.cdc.gov/mmwr/.

Percent of pregnant women receiving prenatal care in the first trimester. HIV patients with CD4 counts less than 200 who received pneumocystis jiroveci pneumonia (PCP) prophylaxis.